Webcast Baveno VIII in Practice: Non-Invasive Risk Stratification of Portal Hypertension

Baveno VIII in Practice: Non-Invasive Risk Stratification of Portal Hypertension

 · Europe/Paris

About This Webcast

Join two leading experts — Prof. Juan Gonzalez Abraldes (University of Alberta, FAASLD) and Dr. Elton Dajti (IRCCS Azienda Ospedaliero-Universitaria di Bologna) — as they translate the new consensus into actionable clinical decisions. In 60 minutes, you will: Master the updated diagnostic algorithms for cACLD and CSPH, including the confirmed Rule of 5 kPa and the added value of spleen stiffness measurement (SSM) with VCTE-100Hz Understand when and how NITs can play a key role in the management of patients with advanced liver disease Apply Baveno VIII to real-world cases — including indeterminate zones, recompensated cirrhosis, patients with HCC, pediatric patients, and patients with vascular liver diseases Work through two live clinical cases with interactive polling, and bring your questions to a dedicated Q&A session. Join us !

Speakers

Prof. Juan Gonzalez Abraldes MD, PhD, FAASLD

Prof. Juan Gonzalez Abraldes MD, PhD, FAASLD

Professor of Medicine and Director of Liver Unit , Division of Gastroenterology, University of Alberta, Edmonton, Canada

⦿Dr. Abraldes is the Director of the Liver Unit and the AHS Hepatology lead for the Edmonton Zone. He is also a member of the division’s Residence Program Committee. He served as the Chair of the Special Interest group in Portal hypertension of the American Society for the Study of the Liver (2017-2018), and currently serves as committee member for the Baveno International Cooperation for the study of Portal Hypertension. He is the co-chair of the research committee for the Canadian Association for the Study of the Liver. He serves as Associate Editor in Hepatology, and on the Editorial Board of Journal of Hepatology and Liver Transplantation. He has co-authored the 2016 American Association for the Study of the liver (AASLD) guidelines for the management of portal hypertension. Dr. Abraldes is an attending physician in the gastroenterology, hepatology and liver transplant units at the University of Alberta Hospital. He sees patients in the outpatient clinic in Hepatology and Liver Transplantation and provides endoscopic services. He is co-director of the multidisciplinary Cirrhosis Care Clinic

Dr. Elton Dajti, MD, PhD

Dr. Elton Dajti, MD, PhD

Gastroenterology Unit , IRCCS AOUBO, Bologna, Italy

Dr. Elton Dajti is currently a physician in the Gastroenterology Unit of IRCCS Azienda Ospedaliero-Universitaria di Bologna. Research activity focuses on liver cirrhosis, portal hypertension, hepatocellular carcinoma, ultrasound and non-invasive tests, and rare liver disease, especially vascular liver diseases. Current projects focus on non-invasive diagnosis of portal hypertension, risk stratification for decompensation, impact of etiological cures in the natural history of cirrhosis, early diagnosis and impact of sarcopenia, novel diagnostic and prognostic markers in steatotic liver disease and vascular liver diseases. He is an active member of the Baveno Cooperation, VALDIG Group, and ERN-LIVER. Within the Baveno Cooperation, Dr. Dajti is a member of the Communication Committee and has participated as a panelist during the Baveno VIII Workshop.